Konstantin Kazankov

  1. 2022
  2. Published

    Gastroenterologi og hepatologi og evidensbaseret sygepleje. / Holm, Pia; Fassov, Janne; Kazankov, Konstantin et al.

    Medicinske sygdomme og evidensbaseret sygepleje. ed. / Steen Hundborg. 1. ed. København : FADL's Forlag, 2022. p. 120-141.

    Research output: Contribution to book/anthology/report/proceedingBook chapterEducationpeer-review

  3. Published

    Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. / Pose, Elisa; Solà, Elsa; Lozano, Juan J et al.

    In: Hepatology communications, Vol. 6, No. 5, 05.2022, p. 1100-1112.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  4. Published

    Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass. / Kazankov, Konstantin; Bojsen-Møller, Kirstine Nyvold; Møller, Holger Jon et al.

    In: Physiological Reports, Vol. 10, No. 2, e15157, 01.2022.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  5. 2021
  6. Published

    Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis : A Danish Nation-wide Cohort Study. / Jepsen, Peter; Tapper, Elliot B.; Deleuran, Thomas et al.

    In: Hepatology, Vol. 74, No. 5, 11.2021, p. 2725-2734.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  7. Published

    The use of Rifaximin in Patients with Cirrhosis. / Caraceni, Paolo; Vargas, Victor; Solà, Elsa et al.

    In: Hepatology, Vol. 74, No. 3, 09.2021, p. 1660-1673.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  8. Published

    Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? / Kjær, Mikkel Breinholt; George, Jacob; Kazankov, Konstantin et al.

    In: Expert Review of Gastroenterology & Hepatology, Vol. 15, No. 1, 01.2021, p. 51-64.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  9. Published

    Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis. / Gantzel, Rasmus Hvidbjerg; Kjær, Mikkel Breinholt; Laursen, Tea Lund et al.

    In: Frontiers in medicine, Vol. 7, 615599, 01.2021.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  10. 2020
  11. Published

    Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease. / Kazankov, Konstantin; Rosso, Chiara; Younes, Ramy et al.

    In: Frontiers in Medicine, Vol. 7, 616212, 12.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  12. Published

    Macrophage markers and innate immunity in cirrhosis. / Grønbæk, Henning; Gantzel, Rasmus Hvidbjerg Birkbak; Laursen, Tea Lund et al.

    In: Journal of Hepatology, Vol. 73, No. 6, 12.2020, p. 1586-1588.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

  13. Published

    Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis. / Laursen, Tea Lund; Sandahl, Thomas Damgaard; Kazankov, Konstantin et al.

    In: American Journal of Physiology: Gastrointestinal and Liver Physiology, Vol. 319, No. 2, 08.2020, p. G151-G156.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  14. Published

    Liver-related effects of chronic hepatitis C antiviral treatment. / Laursen, Tea L.; Sandahl, Thomas D.; Kazankov, Konstantin et al.

    In: World Journal of Gastroenterology, Vol. 26, No. 22, 06.2020, p. 2931-2947.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  15. Published

    Time-dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C. / Laursen, Tea Lund; Siggaard, Cecilie Brøckner; Kazankov, Konstantin et al.

    In: Journal of Viral Hepatitis, Vol. 27, No. 1, 01.2020, p. 28-35.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  16. 2019
  17. Published

    Bariatrisk kirurgi ved non-alkoholisk fedtleversygdom. / Laursen, Tea Lund; Kazankov, Konstantin; Grønbæk, Henning.

    BestPractice. 2019.

    Research output: Other contributionNet publication - Internet publicationResearchpeer-review

  18. Published

    Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease. / Rosso, Chiara; Kazankov, Konstantin; Younes, Ramy et al.

    In: Journal of Hepatology, Vol. 71, No. 5, 11.2019, p. 1012-1021.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  19. Published

    QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites. / Kazankov, Konstantin; Jensen, Henrik Kjaerulf; Watson, Hugh et al.

    In: Scandinavian Journal of Gastroenterology, Vol. 54, No. 11, 11.2019, p. 1376-1378.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

  20. Published

    Metabolic liver function improves 12 weeks after successful sofosbuvir-based direct-acting antiviral therapy in patients with chronic hepatitis C and advanced liver disease. / Laursen, Tea Lund; Siggard, Cecilie Brockner; Kazankov, Konstantin et al.

    2019. E738-E738 Poster session presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Austria.

    Research output: Contribution to conferencePosterResearchpeer-review

  21. Published

    The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. / Kazankov, Konstantin; Jørgensen, Simon Mark Dahl; Thomsen, Karen Louise et al.

    In: Nature Reviews. Gastroenterology & Hepatology, Vol. 16, No. 3, 03.2019, p. 145-159.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  22. Published

    Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. / Laursen, Tea L; Hagemann, Christoffer A; Wei, Chunshan et al.

    In: World Journal of Hepatology, Vol. 11, No. 2, 27.02.2019, p. 138-149.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  23. Published

    Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose. / Siggaard, Cecilie Brøckner; Kazankov, Konstantin; Rødgaard-Hansen, Sidsel et al.

    In: Scandinavian Journal of Gastroenterology, Vol. 54, No. 5, 2019, p. 623-632.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  24. 2018
  25. Published

    Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology. / Lund Laursen, Tea; Siggard, Cecilie Brøckner; Kazankov, Konstantin et al.

    In: Scandinavian Journal of Gastroenterology, Vol. 53, No. 8, 10.07.2018, p. 986-993.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  26. Published

    Svær koronararteriesygdom ved cirrose. / Kazankov, Konstantin.

    In: BestPractice - Gastroenterologi, No. 4, 06.2018, p. 23-25.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleCommunication

  27. Published

    Macrophage Markers are Poorly Associated with Liver Histology in Children with Non-Alcoholic Fatty Liver Disease. / Kazankov, Konstantin; Alisi, Anna; Møller, Holger Jon et al.

    In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 67, No. 5, 2018, p. 635–642.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  28. Published

    Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. / Laursen, Tea Lund; Wong, Grace Lai-Hung; Kazankov, Konstantin et al.

    In: Journal of Gastroenterology and Hepatology, Vol. 3, No. 2, 2018, p. 484–491.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  29. 2017
  30. Published

    Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD. / Eriksen, Peter Lykke; Thomsen, Karen Louise; Laursen, Tea Lund et al.

    In: Current Hepatology Reports, Vol. 16, No. 4, 12.2017, p. 308-316.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  31. Published

    Nonalkoholisk fedtleversygdom hos børn og unge. / Björklund, Jessica; Laursen, Tea Lund; Kazankov, Konstantin et al.

    In: Ugeskrift for Laeger, Vol. 179, No. 18, 09.2017, p. 2-5.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  32. Published

    High burden of coronary atherosclerosis in patients with cirrhosis. / Kazankov, Konstantin; Munk, Kim; Øvrehus, Kristian Altern et al.

    In: European Journal of Clinical Investigation, Vol. 47, No. 8, 08.2017, p. 565-573.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  33. Published

    Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease. / Rødgaard-Hansen, Sidsel; St George, Alexis; Kazankov, Konstantin et al.

    In: Scandinavian journal of clinical and laboratory investigation, Vol. 77, No. 7, 07.2017, p. 498-504.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  34. Published

    Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease. / Møller, Holger Jon; Kazankov, Konstantin; Rødgaard-Hansen, Sidsel et al.

    Biomarkers in Liver Disease (Biomarkers in Disease: Methods, Discoveries and Applications). ed. / Vinood B. Patel; Victor R. Preedy. Springer, 2017. p. 321-348.

    Research output: Contribution to book/anthology/report/proceedingBook chapterResearchpeer-review

  35. 2016
  36. Published

    Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury. / Nielsen, M J; Karsdal, Morten A; Kazankov, K et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 44, No. 11-12, 12.2016, p. 1242-1252.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  37. Published

    Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis. / Grønbaek, H; Kreutzfeldt, Martin Heebøll; Kazankov, K et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 44, No. 10, 11.2016, p. 1062-1070.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  38. Published

    Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children. / Knøsgaard, L; Kazankov, K; Birkebæk, N H et al.

    In: European Journal of Clinical Nutrition, Vol. 70, No. 9, 09.2016, p. 1073-7.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  39. Published

    Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. / Kazankov, Konstantin; Rode, Anthony; Simonsen, Kira Schreiner et al.

    In: Scandinavian Journal of Clinical & Laboratory Investigation, Vol. 76, No. 1, 02.2016, p. 64-73.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  40. Published

    The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. / Kazankov, Konstantin; Barrera, Francisco; Møller, Holger Jon et al.

    In: Liver International, Vol. 36, 2016, p. 1549-1557.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  41. 2015
  42. Published

    Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. / Nielsen, Mette J; Kazankov, Konstantin; Leeming, Diana J et al.

    In: PLOS ONE, Vol. 10, No. 9, 25.09.2015, p. e0137302.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  43. Published

    Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery. / Kazankov, Konstantin; Tordjman, Joan; Møller, Holger Jon et al.

    In: Journal of Gastroenterology and Hepatology, Vol. 30, No. 8, 08.2015, p. 1293-300.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  44. Published

    Reply: Soluble CD163 correlates with the fibrosis models APRI and FIB-4 and independently predicts liver fibrosis in chronic HBV and HCV infection. / Kazankov, Konstantin; Møller, Holger Jon; Bibby, Bo Martin et al.

    In: Hepatology, Vol. 61, No. 1, 05.01.2015, p. 735-736.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  45. Published

    The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. / Kazankov, K; Møller, H J; Lange, Aksel et al.

    In: Pediatric obesity, Vol. 10, No. 3, 2015, p. 226-233.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  46. 2014
  47. Published

    Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis : Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. / Grønbæk, Henning; Kazankov, Konstantin; Jessen, Niels et al.

    2014. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  48. Published

    Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. / Kazankov, Konstantin; Barrera, Francisco; Møller, Holger Jon et al.

    In: Hepatology, Vol. 60, No. 2, 13.03.2014, p. 521.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  49. 2013
  50. Published

    Hepatic macrophage activation predicts clinical decompensation in chronic liver disease. / Rode, Anthony; Nicoll, Amanda; Møller, Holger Jon et al.

    In: Gut, Vol. 62, No. 8, 08.2013, p. 1231-2.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  51. Published

    Change in soluble CD163, a marker of activated macrophages, is associated with improvement in liver enzymes and metabolic profile in obese children during lifestyle intervention. / Kazankov, Konstantin; Lange, Aksel; Birkebæk, Niels et al.

    In: World Journal of Hepatology, Vol. 588, 2013, p. S257.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearchpeer-review

  52. Submitted
  53. 2012
  54. Published

    Prognose og behandling af nonalkoholisk fedtleversygdom og steatohepatitis. / Heebøll, Sara; Kazankov, Konstantin; Poulsen, Marianne Kjær et al.

    In: Ugeskrift for Laeger, Vol. 174, No. 8, 2012, p. 488-490.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearch

  55. 2011
  56. Published

    Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. / Kazankov, Konstantin; Holland-Fischer, Peter; Andersen, Niels Holmark et al.

    In: Liver International, Vol. 31, No. 4, 01.04.2011, p. 534-40.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review